Moderator: Arezki Yaiche, Head of Coverage France & Benelux, Mergermarket (ION Group)
MedTech and diagnostic sectors are changing fast with rising digital medical-grade solutions and the expansion of consumer healthcare, creating new sources of innovations and investment opportunities. How is this impacting the landscape for venture capital investment in MedTech in 2022? How are the interest and profile of the early-stage investors evolving through the continuum of MedTech, digital health and consumer healthcare? To what extent does digital health require different approaches and skills? How are investment strategies diversifying with the emergence of new sources of innovations?